Goodrx Holdings Inc Cl A
(NQ:
GDRX
)
4.150
-0.410 (-8.99%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 15, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Goodrx Holdings Inc Cl A
< Previous
1
2
3
4
5
6
7
8
9
Next >
GOODRX ALERT: Bragar Eagel & Squire, P.C. is Investigating GoodRx Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
November 12, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
GoodRx Reports Third Quarter 2024 Results
November 07, 2024
From
GoodRx Holdings, Inc.
Via
Business Wire
GoodRx to Participate in Upcoming Investor Conferences
November 04, 2024
From
GoodRx Holdings, Inc.
Via
Business Wire
GoodRx Unveils New E-commerce Platform, Launches with Opill®
October 31, 2024
From
GoodRx
Via
Business Wire
GoodRx Announces Exclusive Low Cash Price for QSYMIA®, the Leading Branded Once-Daily Oral Weight Management Medication for Adults
October 29, 2024
From
GoodRx
Via
Business Wire
Ronald E. Bruehlman Joins GoodRx Board of Directors
October 28, 2024
From
GoodRx
Via
Business Wire
GoodRx Announces New Affordability Programs for Menopause Hormone Therapies
October 23, 2024
From
GoodRx
Via
Business Wire
GoodRx Partnering with Retail Pharmacies to Deliver Pay-Over-Time Option Directly to Consumers
October 16, 2024
From
GoodRx
Via
Business Wire
GoodRx Announces Date for Third Quarter 2024 Earnings Release and Conference Call
October 10, 2024
From
GoodRx Holdings, Inc.
Via
Business Wire
GoodRx Announces Lowest Discounted Cash Price at Retail Pharmacy Locations for neffy® (epinephrine nasal spray)
September 26, 2024
From
GoodRx
Via
Business Wire
GOODRX ALERT: Bragar Eagel & Squire, P.C. is Investigating GoodRx Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
September 25, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
GoodRx to Participate in Upcoming Investor Conferences
August 21, 2024
From
GoodRx Holdings, Inc.
Via
Business Wire
GoodRx Reports Second Quarter 2024 Results
August 08, 2024
From
GoodRx Holdings, Inc.
Via
Business Wire
GoodRx Announces Date for Second Quarter 2024 Earnings Release and Conference Call
July 11, 2024
From
GoodRx Holdings, Inc.
Via
Business Wire
Ian T. Clark Joins GoodRx Board of Directors
July 10, 2024
From
GoodRx Holdings, Inc.
Via
Business Wire
GoodRx Launches New “Prescription Cost Tracker” to Spotlight Key Factors Driving Out-of-Pocket Medication Costs in the U.S.
June 26, 2024
From
GoodRx
Via
Business Wire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of GoodRx
June 21, 2024
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
GDRX Investors Have Opportunity to Lead GoodRx Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm
June 21, 2024
From
The Schall Law Firm
Via
Business Wire
GoodRx Holdings, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - GDRX
June 21, 2024
From
DJS Law Group
Via
Business Wire
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against GoodRx Holdings, Inc. (GDRX)
June 20, 2024
From
The Law Offices of Frank R. Cruz
Via
Business Wire
GDRX Investors Have Opportunity to Lead GoodRx Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm
June 20, 2024
From
The Schall Law Firm
Via
Business Wire
GDRX Investors Have Opportunity to Lead GoodRx Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm
June 18, 2024
From
Schall Law
Via
GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against GoodRx, Exscientia, Malibu Boats, and Equinix and Encourages Investors to Contact the Firm
June 17, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
GDRX Investors Have Opportunity to Join GoodRx Holdings, Inc. Securities Fraud Investigation with the Schall Law Firm
June 17, 2024
From
The Schall Law Firm
Via
Business Wire
GOODRX HOLDINGS, INC. (NASDAQ: GDRX) INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against GoodRx Holdings, Inc.
June 17, 2024
From
Bernstein Liebhard LLP
Via
GlobeNewswire
Rosen Law Firm Urges GoodRx Holdings, Inc. (GDRX) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
June 14, 2024
From
The Rosen Law Firm, P.A.
Via
Business Wire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of GoodRx
June 12, 2024
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against GoodRx, Exscientia, Malibu Boats, and Globe Life and Encourages Investors to Contact the Firm
June 11, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
GDRX INVESTOR ALERT: Kirby McInerney LLP Notifies GoodRx Holdings, Inc. Investors of Upcoming Lead Plaintiff Deadline in Class Action Lawsuit
June 11, 2024
From
Kirby McInerney LLP
Via
Business Wire
INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in GoodRx Holdings, Inc. with Losses to Contact the Firm
June 11, 2024
From
Schall Law
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.